State Street Corp Xencor Inc Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Xencor Inc stock. As of the latest transaction made, State Street Corp holds 3,119,290 shares of XNCR stock, worth $83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,119,290
Previous 3,352,376 6.95%
Holding current value
$83 Million
Previous $63.5 Million 1.15%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.7 - $21.65 $3.66 Million - $5.05 Million
-233,086 Reduced 6.95%
3,119,290 $62.7 Million
Q2 2024

Aug 14, 2024
SELL
$18.21 - $24.5 $16.1 Million - $21.6 Million
-883,067 Reduced 20.85%
3,352,376 $63.5 Million
Q1 2024

May 15, 2024
BUY
$18.65 - $26.52 $16.9 Million - $24.1 Million
908,587 Added 27.31%
4,235,443 $93.7 Million
Q4 2023

Feb 14, 2024
BUY
$16.53 - $21.42 $5.76 Million - $7.46 Million
348,255 Added 11.69%
3,326,856 $70.6 Million
Q3 2023

Nov 14, 2023
SELL
$20.08 - $25.39 $2.51 Million - $3.17 Million
-124,976 Reduced 4.03%
2,978,601 $60 Million
Q2 2023

Aug 14, 2023
SELL
$24.77 - $29.9 $4.37 Million - $5.28 Million
-176,591 Reduced 5.38%
3,103,577 $77.5 Million
Q1 2023

May 15, 2023
BUY
$25.95 - $36.95 $3.22 Million - $4.59 Million
124,117 Added 3.93%
3,280,168 $91.5 Million
Q4 2022

Feb 14, 2023
SELL
$24.79 - $30.86 $2.46 Million - $3.07 Million
-99,401 Reduced 3.05%
3,156,051 $82.2 Million
Q3 2022

Nov 15, 2022
BUY
$24.62 - $32.44 $183,936 - $242,359
7,471 Added 0.23%
3,255,452 $84.6 Million
Q2 2022

Aug 15, 2022
BUY
$19.74 - $29.01 $5.51 Million - $8.1 Million
279,080 Added 9.4%
3,247,981 $88.9 Million
Q1 2022

May 16, 2022
BUY
$26.68 - $41.63 $13 Million - $20.3 Million
488,131 Added 19.68%
2,968,901 $79.2 Million
Q4 2021

Feb 14, 2022
SELL
$33.67 - $43.44 $3.45 Million - $4.46 Million
-102,563 Reduced 3.97%
2,480,770 $99.5 Million
Q3 2021

Nov 15, 2021
SELL
$30.65 - $35.68 $690,544 - $803,870
-22,530 Reduced 0.86%
2,583,333 $84.4 Million
Q2 2021

Aug 16, 2021
BUY
$34.33 - $44.68 $652,853 - $849,679
19,017 Added 0.74%
2,605,863 $89.9 Million
Q1 2021

May 17, 2021
BUY
$40.81 - $53.88 $5.27 Million - $6.96 Million
129,087 Added 5.25%
2,586,846 $111 Million
Q4 2020

Feb 16, 2021
BUY
$36.63 - $47.63 $1.88 Million - $2.45 Million
51,392 Added 2.14%
2,457,759 $107 Million
Q3 2020

Nov 10, 2020
SELL
$30.09 - $43.02 $10.7 Million - $15.3 Million
-356,094 Reduced 12.89%
2,406,367 $93.3 Million
Q2 2020

Aug 14, 2020
BUY
$27.76 - $33.42 $18.2 Million - $21.9 Million
654,370 Added 31.04%
2,762,461 $89.5 Million
Q1 2020

May 11, 2020
BUY
$20.69 - $37.79 $43.6 Million - $79.7 Million
2,108,091 New
2,108,091 $63 Million

Others Institutions Holding XNCR

# of Institutions
216
Shares Held
71.8M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.59B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email